Drugs / E2MATE
E2MATE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01631981 | Jun 2012 → Oct 2013 | endometriosis | PregLem SA | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E2MATE | “PGL2001(estradiol sulfamate, E2MATE, ZK190628), Tablets, 1mg.” NCT01631981 ↗ |
| Known as | estradiol sulfamate | “PGL2001(estradiol sulfamate, E2MATE, ZK190628), Tablets, 1mg.” NCT01631981 ↗ |
| Known as | Estradiol-3-O-Sulfamate | ChEMBL registry synonym — accepted as the source's own label CHEMBL219321 ↗ |
| Known as | PGL2001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01631981 ↗ |
| Known as | ZK190628 | “PGL2001(estradiol sulfamate, E2MATE, ZK190628), Tablets, 1mg.” NCT01631981 ↗ |
| Action | Inhibit | “steroid sulfatase inhibitor PGL2001” NCT01631981 ↗ |
| Modality | Small molecule | — CHEMBL219321 ↗ |